Amorphous calcium phosphate (ACP) in tissue repair process

Microsc Res Tech. 2018 Jun;81(6):579-589. doi: 10.1002/jemt.23013. Epub 2018 Mar 13.

Abstract

Synthetic biomaterials submitted to new structural technologies have become ideal for the recovery of traumatized bone tissues and some bone substitutes such as bioactive glass, β-Tricalcium phosphate (β-TCP) and amorphous calcium phosphate (ACP) are being used in areas of tissue defects. For this study, ACP was produced in the form of fibers and then submitted to cytotoxicity testing. A sample of ACP was inserted into the mandibular region of a patient with a lost implant so after removal and curettage, the remaining bone site was filled with the ACP biomaterial. Preliminary cytotoxicity test was negative. After 15 weeks of healing, a titanium implant was inserted at the site. Clinical and radiographic follow-up was conducted for 12 months and sequential radiographic analyses revealed tissue formation resembling spongy bone. Images under immunohistochemistry demonstrated efficient deposition and osteoconduction of the newly deposited tissue. Residual portion of the CaO:P2 O5 outer layers served as a substrate for osteoid matrix deposition, aiding growth, and the results of fiber absorption favored maturation of the new bone tissue.

Keywords: amorphous calcium phosphate; cytotoxicity; implant; osteoconduction.

MeSH terms

  • Apatites / metabolism
  • Biocompatible Materials / pharmacology*
  • Bone Substitutes / pharmacology*
  • Calcium Phosphates / pharmacology*
  • Dental Implantation / methods
  • Humans
  • Osseointegration / physiology
  • Osteogenesis / drug effects*
  • Wound Healing / drug effects*

Substances

  • Apatites
  • Biocompatible Materials
  • Bone Substitutes
  • Calcium Phosphates
  • amorphous calcium phosphate
  • tricalcium phosphate